Graft Vessel Disease: The Impact of Immunosuppression and Possible Treatment Strategies
- 1 August 1993
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 134 (1) , 99-116
- https://doi.org/10.1111/j.1600-065x.1993.tb00641.x
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Prevention of restenosis by lovastatin after successful coronary angioplastyAmerican Heart Journal, 1991
- Peptide inhibition of neointimal hyperplasia in vein graftsJournal of Vascular Surgery, 1991
- Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytesPharmacological Research, 1991
- EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITROTransplantation, 1989
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human AtheromaNew England Journal of Medicine, 1988
- Cardiac Transplantation: Where Are We?New England Journal of Medicine, 1986
- Long-term results, hemodynamics, and complications after combined heart and lung transplantation.Circulation, 1985
- HEART GRAFT ARTERIOSCLEROSISTransplantation, 1985
- CIRCULATING ANTIBODY FOLLOWING CARDIAC TRANSPLANTATION IN Ag-B-COMPATIBLE RATS1Transplantation, 1972